Clinical Trial Update: Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels [Phase 4]

View source ↗

Summary

A Phase 4 trial studying the effects of supplementary omega-3 on serum C-reactive protein levels in coronary artery disease and atherosclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Coronary Artery Disease, Inflammatory Response | Phase 4 | Status: TERMINATED